Overview

A Safety/Efficacy Study of Intra-coronary Tenecteplase During Balloon Angioplasty to Treat Heart Attacks

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to gather preliminary data regarding the angiographic efficacy of the administration of low-dose adjunctive intracoronary (IC) tenecteplase during balloon angioplasty for heart attacks. We hypothesize that low-dose IC tenecteplase will enhance the breakdown of blood clots at the site of the culprit lesion leading to reduced damage to the heart muscle.
Phase:
Phase 2
Details
Lead Sponsor:
C. Michael Gibson, MS, MD
Collaborator:
Genentech, Inc.
Treatments:
Tenecteplase
Tissue Plasminogen Activator